UGT1A1 genotype as an indicator of neutropenia for FOLFOXIRI with bevacizumab in patients with mCRC (QUATTRO study)

被引：0
|
作者：
Oki, Eiji [1 ]
Yoshino, Takayuki [2 ]
Muro, Kei [3 ]
Emi, Yasunori [4 ]
Tsuji, Akihito [5 ]
Yamasaki, Kentaro [10 ]
Yamanaka, Takeharu [7 ]
Sakisaka, Hideki [6 ]
Kato, Takeshi [8 ]
Kanazawa, Akiyoshi [9 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[4] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan
[5] Kagawa Univ, Takamatsu, Kagawa, Japan
[6] Osaka Minato Cent Hosp, Osaka, Japan
[7] Yokohama City Univ, Yokohama, Kanagawa, Japan
[8] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
[9] Kitano Hosp, Osaka, Japan
[10] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-17-2
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Genotype depended inducibility of UGT1A1 mRNA expression in human duodenum
    Remmler, C
    Haenisch, S
    Hecker, U
    Siegmund, W
    Cascorbi, I
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 717 - 718
  • [42] Genotype dependent inducibility of UGT1A1 mRNA expression in human duodenum
    Remmler, Cornelia
    Haenisch, Sierk
    Giessmann, Thomas
    Lerch, Markus M.
    Siegmund, Werner
    Cascorbi, Ingolf
    DRUG METABOLISM REVIEWS, 2006, 38 : 53 - 53
  • [43] UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
    Masahide Onoue
    Tomohiro Terada
    Masahiko Kobayashi
    Toshiya Katsura
    Shigemi Matsumoto
    Kazuhiro Yanagihara
    Takafumi Nishimura
    Masashi Kanai
    Satoshi Teramukai
    Akira Shimizu
    Masanori Fukushima
    Ken-ichi Inui
    International Journal of Clinical Oncology, 2009, 14 : 136 - 142
  • [44] UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
    Onoue, Masahide
    Terada, Tomohiro
    Kobayashi, Masahiko
    Katsura, Toshiya
    Matsumoto, Shigemi
    Yanagihara, Kazuhiro
    Nishimura, Takafumi
    Kanai, Masashi
    Teramukai, Satoshi
    Shimizu, Akira
    Fukushima, Masanori
    Inui, Ken-ichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) : 136 - 142
  • [45] UGT1A1*6 IS A PREDICTIVE MARKER OF SEVERE NEUTROPENIA FOR METASTATIC CRC PATIENTS RECEIVED FOLFIRI IN JAPAN
    Hazama, S.
    Okuyama, Y.
    Kato, T.
    Takahashi, K.
    Nozawa, H.
    Okayama, N.
    Hinoda, Y.
    Oka, M.
    Sakamoto, J.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 138 - 138
  • [46] UGT1A1 promoter genotype correlates with pharmacokinetics but not toxicity in patients receiving protracted irinotecan (IRN).
    Stewart, C. F.
    Panetta, J. C.
    O'Shaughnessy, M.
    Throm, S.
    Liu, T.
    Billups, C.
    Gajjar, A.
    Furman, W. L.
    McGregor, L. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 140S - 140S
  • [47] Analysis of DPYD and UGT1A1 genotype in patients with advanced pancreatic cancer treated with modified FOLFIRINOX
    Vivaldi, C.
    Arrigoni, E.
    Morganti, R.
    Catanese, S.
    Fidilio, L.
    Pecora, I.
    Restante, G.
    Fornaro, L.
    Crucitta, S.
    Lencioni, M.
    Rofi, E.
    Vasile, E.
    Falcone, A.
    Danesi, R.
    Del Re, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] HOW UGT1A1 GENOTYPE IMPACTS ON TKI EFFICACY AND SAFETY IN CHRONIC MYELOID LEUKEMIA PATIENTS
    Iurlo, A.
    Bucelli, C.
    Cattaneo, D.
    Levati, G.
    Tavazzi, D.
    Consonni, D.
    Baldini, L.
    Cappellini, M. D.
    HAEMATOLOGICA, 2019, 104 : 143 - 144
  • [49] THE UGT1A1 GENOTYPE INFLUENCES THE SURVIVAL OF PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA OF INTERMEDIATE CITOGENETIC RISK
    Diaz Santa, J.
    Rodriguez Romanos, R.
    Osca Gelis, G.
    Coll Jorda, R.
    Pratcorona, M.
    Moret Puig, C.
    Escoda, L.
    Heras, I
    Arnan, M.
    Vives, S.
    Salamero, O.
    Lloveras Guelquee, N.
    Bargay, J.
    Sampol, A.
    Cruz Garcia, D.
    Garcia, A.
    Quinones, T.
    Sierra, J.
    Esteve, J.
    Tormo, M.
    Tuset Andujar, E.
    Gallardo Giralt, D.
    HAEMATOLOGICA, 2019, 104 : 268 - 269
  • [50] Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
    Jada, Srinivasa Rao
    Lim, Robert
    Wong, Chiung Ing
    Shu, Xiaochen
    Lee, Soo Chin
    Zhou, Qingyu
    Goh, Boon Cher
    Chowbay, Balram
    CANCER SCIENCE, 2007, 98 (09): : 1461 - 1467
12345